Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Neale

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Health Progress (Saint Louis, Mo.)|February 6, 2007
Who really wants health care justice?Ann Neale
Origins|March 2, 1978
Ethical reflections on scientific researchAnn Neale
Health Progress (Saint Louis, Mo.)|September 1, 1992
Helpful analysis of statement on nutrition and hydrationAnn Neale
Health Progress (Saint Louis, Mo.)|May 28, 2004
An opportunity for civic leadership. In advocating health care reform, our ministry can also help reinvigorate U.S. democracyAnn Neale
Delaware Medical Journal|June 1, 2007
Daniel Callahan redux--business and medicine, "can this marriage work?"James Giordano, Ann Neale
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsSam L Teichman, Ann Neale, Betty Lawrence, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2017
Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy VolunteersKirk W Johnson, Ann Neale, Allan Gordon, et al.
Journal of Opioid Management|February 27, 2007
A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgiaMark S Wallace, Dwight Moulin, A J M Clark, et al.
Clinical and Translational Science|March 18, 2022
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjectsSibel Ucpinar, Borje Darpo, Ann Neale, et al.
The Lancet. Neurology|July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trialRobert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Health Progress (Saint Louis, Mo.)|February 6, 2007
Who really wants health care justice?Ann Neale
Origins|March 2, 1978
Ethical reflections on scientific researchAnn Neale
Health Progress (Saint Louis, Mo.)|September 1, 1992
Helpful analysis of statement on nutrition and hydrationAnn Neale
Health Progress (Saint Louis, Mo.)|May 28, 2004
An opportunity for civic leadership. In advocating health care reform, our ministry can also help reinvigorate U.S. democracyAnn Neale
Delaware Medical Journal|June 1, 2007
Daniel Callahan redux--business and medicine, "can this marriage work?"James Giordano, Ann Neale
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsSam L Teichman, Ann Neale, Betty Lawrence, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2017
Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy VolunteersKirk W Johnson, Ann Neale, Allan Gordon, et al.
Journal of Opioid Management|February 27, 2007
A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgiaMark S Wallace, Dwight Moulin, A J M Clark, et al.
Clinical and Translational Science|March 18, 2022
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjectsSibel Ucpinar, Borje Darpo, Ann Neale, et al.
The Lancet. Neurology|July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trialRobert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
Pageof 2